- Home
- GRVY vs MGTX Comparison
GRVY vs MGTX Comparison
Compare GRVY & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRVY
- MGTX
- Stock Information
- Founded
- GRVY 2000
- MGTX 2015
- Country
- GRVY South Korea
- MGTX United States
- Employees
- GRVY N/A
- MGTX N/A
- Industry
- GRVY Business Services
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GRVY Consumer Discretionary
- MGTX Health Care
- Exchange
- GRVY Nasdaq
- MGTX Nasdaq
- Market Cap
- GRVY 430.3M
- MGTX 479.9M
- IPO Year
- GRVY 2005
- MGTX N/A
- Fundamental
- Price
- GRVY $60.52
- MGTX $7.30
- Analyst Decision
- GRVY
- MGTX Strong Buy
- Analyst Count
- GRVY 0
- MGTX 2
- Target Price
- GRVY N/A
- MGTX $23.50
- AVG Volume (30 Days)
- GRVY 17.8K
- MGTX 278.8K
- Earning Date
- GRVY 11-12-2024
- MGTX 03-13-2025
- Dividend Yield
- GRVY N/A
- MGTX N/A
- EPS Growth
- GRVY N/A
- MGTX N/A
- EPS
- GRVY 9.14
- MGTX N/A
- Revenue
- GRVY $381,080,758.00
- MGTX $13,929,000.00
- Revenue This Year
- GRVY N/A
- MGTX N/A
- Revenue Next Year
- GRVY N/A
- MGTX $1,391.84
- P/E Ratio
- GRVY $6.62
- MGTX N/A
- Revenue Growth
- GRVY N/A
- MGTX 108.24
- 52 Week Low
- GRVY $57.37
- MGTX $3.85
- 52 Week High
- GRVY $88.85
- MGTX $7.80
- Technical
- Relative Strength Index (RSI)
- GRVY 41.49
- MGTX 66.58
- Support Level
- GRVY $60.05
- MGTX $6.72
- Resistance Level
- GRVY $64.41
- MGTX $7.06
- Average True Range (ATR)
- GRVY 1.54
- MGTX 0.37
- MACD
- GRVY -0.18
- MGTX 0.05
- Stochastic Oscillator
- GRVY 11.48
- MGTX 71.61
About GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.